209 related articles for article (PubMed ID: 33837266)
1. Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
Tokida R; Uehara M; Nakano M; Suzuki T; Sakai N; Ikegami S; Takahashi J; Nakamura Y; Kato H
Sci Rep; 2021 Apr; 11(1):7822. PubMed ID: 33837266
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Bone Turnover / Quality Markers and Bone Mineral Density in Prostate Cancer Patients Receiving Androgen Deprivation Therapy with or without Denosumab.
Miyazawa Y; Sekine Y; Syuto T; Nomura M; Koike H; Matsui H; Shibata Y; Ito K; Suzuki K
Anticancer Res; 2017 Jul; 37(7):3667-3671. PubMed ID: 28668858
[TBL] [Abstract][Full Text] [Related]
3. Association of Bone Metabolism with Fatty Liver Disease in the Elderly in Japan: A Community-based Study.
Mikami K; Endo T; Sawada N; Igarashi G; Kimura M; Hasegawa T; Iino C; Sawada K; Nakaji S; Ishibashi Y; Matsuzaka M; Fukuda S
Intern Med; 2020 May; 59(10):1247-1256. PubMed ID: 32101831
[TBL] [Abstract][Full Text] [Related]
4. Modeling and simulation of bone mineral density in Japanese osteoporosis patients treated with zoledronic acid using tartrate-resistant acid phosphatase 5b, a bone resorption marker.
Mori Y; Kasai H; Ose A; Serada M; Ishiguro M; Shiraki M; Tanigawara Y
Osteoporos Int; 2018 May; 29(5):1155-1163. PubMed ID: 29423715
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and Calcium Addition during Denosumab Therapy over a Period of Four Years Significantly Improves Lumbar Bone Mineral Density in Japanese Osteoporosis Patients.
Suzuki T; Nakamura Y; Kato H
Nutrients; 2018 Feb; 10(3):. PubMed ID: 29495518
[TBL] [Abstract][Full Text] [Related]
6. Relevance of parathyroid hormone (PTH), vitamin 25(OH)D3, calcitonin (CT), bone metabolic markers, and bone mass density (BMD) in 860 female cases.
Zhang M; Li Y; Ma Q; Mao W; Gao Y; Liu Y; Liang B
Clin Exp Obstet Gynecol; 2015; 42(2):129-32. PubMed ID: 26054103
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of bone turnover markers in rapidly destructive coxopathy.
Abe H; Sakai T; Ogawa T; Takao M; Nishii T; Nakamura N; Sugano N
J Bone Miner Metab; 2017 Jul; 35(4):412-418. PubMed ID: 27550182
[TBL] [Abstract][Full Text] [Related]
8. Screening osteoporotic femoral neck without measuring bone mineral density with the use of tartrate resistant acid phosphatase-5b and serum-creatinine-to-cystatin C ratio in Japanese postmenopausal women.
Yoshii I; Chijiwa T; Sawada N
J Orthop Sci; 2020 Jul; 25(4):671-676. PubMed ID: 31337577
[TBL] [Abstract][Full Text] [Related]
9. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
10. TRACP-5b/BAP Score After 3 Months of Treatment With Combined SERM/E2 Therapy Can Predict Changes in Lumbar Spine Bone Mineral Density After 1 Year of Treatment in Early Postmenopausal Osteopenia.
Ota I; Ota Y; Ota K; Eda H; Ohta H
JBMR Plus; 2022 Nov; 6(11):e10690. PubMed ID: 36398113
[TBL] [Abstract][Full Text] [Related]
11. Effect of osteoporosis medication on changes in bone mineral density and bone turnover markers after 24-month administration of daily teriparatide: comparison among minodronate, raloxifene, and eldecalcitol.
Nakatoh S
J Bone Miner Metab; 2018 Mar; 36(2):221-228. PubMed ID: 28293779
[TBL] [Abstract][Full Text] [Related]
12. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
13. Serum bone alkaline phosphatase is a useful marker to evaluate lumbar bone mineral density in Japanese postmenopausal osteoporotic women during denosumab treatment.
Nakamura Y; Suzuki T; Kato H
Ther Clin Risk Manag; 2017; 13():1343-1348. PubMed ID: 29062234
[TBL] [Abstract][Full Text] [Related]
14. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
Szulc P; Munoz F; Marchand F; Chapuy MC; Delmas PD
Calcif Tissue Int; 2003 Dec; 73(6):520-30. PubMed ID: 12958693
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
16. Bone turnover in passive smoking female rat: relationships to change in bone mineral density.
Gao SG; Li KH; Xu M; Jiang W; Shen H; Luo W; Xu WS; Tian J; Lei GH
BMC Musculoskelet Disord; 2011 Jun; 12():131. PubMed ID: 21663694
[TBL] [Abstract][Full Text] [Related]
17. Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.
Iba K; Sonoda T; Takada J; Dohke T; Yamashita T
J Bone Miner Metab; 2017 Mar; 35(2):171-176. PubMed ID: 26832388
[TBL] [Abstract][Full Text] [Related]
18. Utility of serum tartrate-resistant acid phosphatase isoform 5b, bone alkaline phosphatase and osteocalcin in osteoporotic fractures in Chinese patients.
Cao Y; Liu X; Xu H
Clin Lab; 2012; 58(7-8):845-50. PubMed ID: 22997989
[TBL] [Abstract][Full Text] [Related]
19. Altered levels of BMD, PRL, BAP and TRACP-5b in male chronic patients with schizophrenia.
Du X; Ye F; Li J; Zhao Y; Xiao W; Tang X; Zhang X
Sci Rep; 2020 Aug; 10(1):13598. PubMed ID: 32788631
[TBL] [Abstract][Full Text] [Related]
20. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]